A new study from Columbia University College of Physicians and Surgeons (P&S) and Stanford University suggests that the malfunctioning of brain cells called astrocytes may be behind the accumulation of amyloid protein in the brains of patients with Alzheimer's disease.

Share This

A new study from Columbia University College of Physicians and Surgeons (P&S) and Stanford University suggests that the malfunctioning of brain cells called astrocytes may be behind the accumulation of amyloid protein in the brains of patients with Alzheimer's disease.

Related Articles

Alzheimer's disease, most researchers believe, is caused when small peptides called beta-amyloid accumulate in the brain. Everyone makes these peptides at all times during their life, but in people with Alzheimer's, either too much is made or too little is degraded or both. The resulting excess of peptides aggregate together in plaques. Beta-amyloid plaques then lead to death of neurons and dementia. Researchers have known that microglia cells in the brain, which surround the plaques, can ingest and destroy the plaque's proteins in cell culture, so they've been trying to stimulate the cells to do so in vivo. But the role of other cells that surround the plaques, the astrocytes, hasn't been clear. The new findings show that normal astrocytes can also degrade plaque proteins, suggesting that treatments to boost astrocyte activity in Alzheimer's disease may be beneficial.

The study is published in the advanced online edition of Nature Medicine and will be featured in the April issue of the publication.

"This is the first study to show that astrocytes can remove beta-amyloid deposits from brain tissue," says the study's senior author, Dr. Jens Husemann, associate research scientist in the Department of Physiology and Cellular Biophysics at P&S. "In addition, astrocytes outnumber microglia in the brain, so they may be very important. Now researchers will explore ways to activate astrocytes to increase beta-amyloid removal."

"This study contributes to our knowledge of the function of these immune processes, information that may provide opportunities to develop better treatments," says Dr. Bill Thies, vice president of medical and scientific affairs at the Alzheimer's Association, one of the sponsors of this research. (The work was also supported by the Alzheimer's Disease Research Center at Columbia University and the National Institute on Aging.)

The research group, including Dr. Samuel Silverstein, John C. Dalton Professor of Physiology & Cellular Biophysics at P&S, Dr. John Loike, research scientist in the Department of Physiology & Cellular Biophysics at P&S, and Dr. Tony Wyss-Coray, assistant professor of neurology at Stanford University, also speculates that Alzheimer's disease may result from problems with the astrocytes. It is still unknown why beta-amyloid accumulates in people with the late-onset form of the disease, but one possibility is that the astrocytes fail to degrade the proteins. Dr. Husemann and his colleagues are now looking at astrocytes from the brains of Alzheimer's patients and mice with a similar disease to see if the cells are still capable of destroying beta-amyloid.

In the Nature Medicine study, the researchers found that astrocytes ingest beta-amyloid when they placed cultured adult mouse astrocytes onto brain tissue taken from Alzheimer's model mice. The cells reduced the amount of beta amyloid in the brain tissue by 40 percent during the 24-hour experiment.

To see if the astrocytes also degraded the protein, they kept track of the protein in astrocytes cultured in broth. At the beginning of the incubation, all protein was in the broth. In the next 24 hours, the researchers saw that all of the protein moved into the cells, and then disappeared completely, indicating the cells had degraded the beta amyloid and not exported it.

Though the researchers suggest that improving astrocyte's ability to degrade beta-amyloid may be therapeutic, they also caution that other astrocyte functions may contribute to the disease. "Some people think that if the cells don't migrate to plaques, the astrocytes may not release inflammatory molecules that damage the surrounding brain tissue," Dr. Husemann says. "It will be a delicate balancing act to stimulate plaque removal while keeping inflammation down at the same time."

Columbia University College Of Physicians And Surgeons. "Columbia University Researchers Identify Possible New Culprit In Alzheimer's Disease Plaque Formation." ScienceDaily. ScienceDaily, 12 March 2003. <www.sciencedaily.com/releases/2003/03/030312072322.htm>.

Columbia University College Of Physicians And Surgeons. (2003, March 12). Columbia University Researchers Identify Possible New Culprit In Alzheimer's Disease Plaque Formation. ScienceDaily. Retrieved March 31, 2015 from www.sciencedaily.com/releases/2003/03/030312072322.htm

Columbia University College Of Physicians And Surgeons. "Columbia University Researchers Identify Possible New Culprit In Alzheimer's Disease Plaque Formation." ScienceDaily. www.sciencedaily.com/releases/2003/03/030312072322.htm (accessed March 31, 2015).

More From ScienceDaily

More Mind & Brain News

Featured Research

Mar. 31, 2015 — Memory and as well as connections between brain cells were restored in mice with a model of Alzheimer's given an experimental cancer drug, researchers report. "With this treatment, cells under ... full story

Mar. 31, 2015 — A criminologist finds that solitary confinement does not deter inmates from committing further violence in prison. The prisoners in the study who received solitary confinement were no more -- or less ... full story

Mar. 31, 2015 — Alcoholism takes a toll on every aspect of a person's life, including skin problems. Now, a new research report helps explain why this happens and what might be done to address it. "The clinical ... full story

Mar. 31, 2015 — Human language likely developed quite rapidly into a sophisticated system, a linguist contends. Instead of mumbles and grunts, people deployed syntax and structures resembling the ones we use today, ... full story

Mar. 31, 2015 — Coronary heart disease and stroke, two of the leading causes of death in the United States, are diseases associated with heightened platelet reactivity. A new study in humans suggests an underlying ... full story

Mar. 31, 2015 — A new study had researchers seeking answers to why the therapeutic benefit afforded by SSRIs was so limited in children and teenagers. If researchers can uncover the biological mechanisms preventing ... full story

Mar. 31, 2015 — New research reveals high-quality early education is especially advantageous for children when they start younger and continue longer. Not only does more high-quality early education significantly ... full story

Mar. 31, 2015 — During prenatal development, the brains of most animals, including humans, develop specifically male or female characteristics. But scientists have known little about the details of how this ... full story

Mar. 31, 2015 — A history of depression may put women at risk for developing diabetes during pregnancy, according to research. This study also pointed to how common depression is during pregnancy and the need for ... full story

Featured Videos

AAA: Distracted Driving a Serious Teen Problem

AP (Mar. 25, 2015) — While distracted driving is not a new problem for teens, new research from the AAA Foundation for Traffic Safety says it&apos;s much more serious than previously thought. (March 25)
Video provided by AP

Many Don't Know They Have Alzheimer's, But Their Doctors Do

Newsy (Mar. 24, 2015) — According to a new study by the Alzheimer&apos;s Association, more than half of those who have the degenerative brain disease aren&apos;t told by their doctors.
Video provided by Newsy

A Quick 45-Minute Nap Can Improve Your Memory

Newsy (Mar. 23, 2015) — Researchers found those who napped for 45 minutes to an hour before being tested on information recalled it five times better than those who didn&apos;t.
Video provided by Newsy

Related Stories

Mar. 2, 2015 — Amyloid -- an abnormal protein that's a hallmark of Alzheimer's -- starts accumulating inside neurons of people as young as 20, reports a study. This is the first time amyloid accumulation ... full story

Oct. 3, 2013 — Autophagy, a key cellular auto-cleaning mechanism, mediates the formation of amyloid beta plaques, one of the hallmarks of Alzheimer's disease. It might be a potential drug target for the ... full story

Oct. 10, 2012 — Alzheimer’s disease is a severe neurodegenerative disease that affects 45% of people over 85 years of age. Medical researchers have now identified astrocytes as a novel target for the development ... full story

May 22, 2012 — When brain cells start oozing too much of the amyloid protein that is the hallmark of Alzheimer's disease, the astrocytes that normally nourish and protect them deliver a suicide package ... full story

ScienceDaily features breaking news and videos about the latest discoveries in health, technology, the environment, and more -- from major news services and leading universities, scientific journals, and research organizations.